arrow
L

Lin Peng

Sichuan University
H指数:14
被引数:699
浏览量:0

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Identification and validation of neural infiltration-associated biomarkers and their potential regulatory mechanisms in osteosarcoma

骨肉瘤中神经浸润相关生物标志物的鉴定与验证及其潜在调控机制

2026-09-280
OAAI
Advances in drug delivery systems for intracellular infections: minimizing antibiotic dependency

细胞内感染药物递送系统进展:减少抗生素依赖

2026-02-040
PRE
Transcriptomics-based analysis of key genes and potential mechanism and therapeutic agents in cadmium-induced esophageal squamous cell carcinoma progression

基于转录组学的关键基因、潜在机制和疗法药物在镉诱导的食管鳞状细胞癌进展中的分析

2025-12-250
OAAI
Involved-Field Irradiation Versus Elective Nodal Irradiation in Patients With Locally Advanced Esophageal Squamous Cell Carcinoma Treated With Neoadjuvant Chemoradiotherapy

受累野照射与选择性淋巴结照射在经新辅助化放疗治疗的局部晚期食管鳞状细胞癌患者中的比较

2025-11-300
OAAI
Long-term outcomes of minimally invasive esophagectomy vs. open esophagectomy in older patients with esophageal squamous cell carcinoma: a propensity score matching analysis
2025-10-270
OA
Real-world efficacy of PD-1 inhibitors in treating oesophageal squamous cell carcinoma (ESCAPE): protocol of a multicentre, real-world, observational, cohort study
2025-10-210
OA
Lymph node ratio predicts adjuvant chemotherapy benefit in esophageal squamous cell carcinoma

淋巴结比率预测食管鳞状细胞癌辅助化疗的获益。

2025-10-010
OAAI
Reply: Intrathoracic versus cervical anastomosis in esophagectomy: The analyses for middle and lower thoracic esophageal squamous cell carcinoma

回复:食管切除术中的胸内 versus 颈部吻合术:中下胸段食管鳞状细胞癌的分析

2025-05-060
PRE
Sex-based analysis of clinical outcomes in elderly patients with esophageal squamous cell carcinoma post-esophagectomy: a propensity score matching analysis

基于性别的老年食管鳞状细胞癌患者术后临床结局分析:一项倾向性评分匹配分析

2025-04-140
OA
Long-term survival outcomes of esophageal squamous cell carcinoma with intraoperative thoracic duct ligation: a large-scale propensity score matching analysis
2025-03-050
OAAI
ASO Visual Abstract: Prognostic Impact of Sarcopenia and Surgical Timing in Locally Advanced Esophageal Squamous Cell Carcinoma Receiving Neoadjuvant Chemoradiotherapy-TIMES Study
2025-03-010
PRE
Prognostic Impact of Sarcopenia and Surgical Timing in Locally Advanced Esophageal Squamous Cell Carcinoma Receiving Neoadjuvant Chemoradiotherapy: TIMES Study
2025-02-091
PRE
Osimertinib as a neoadjuvant therapy in resectable EGFR-mutant non-small cell lung cancer: a real-world, multicenter retrospective study

奥希替尼作为可切除EGFR突变非小细胞肺癌的新辅助治疗:一项真实世界、多中心回顾性研究

2024-12-010
OAAI
Toripalimab plus chemotherapy and radiotherapy for treatment-naive advanced esophageal squamous cell carcinoma: a single-arm phase 2 trial
2024-08-200
OAAI
Reduction in chemotherapy relative dose intensity decreases overall survival of neoadjuvant chemoradiotherapy in patients with locally advanced esophageal carcinoma
2024-08-020
OAAI
Impact of Metastatic Lymph Nodes on Survival of Patients with pN1-Category Esophageal Squamous Cell Carcinoma: A Long-Term Survival Analysis

淋巴结转移对pN1-Category食管鳞癌患者生存的影响: 长期生存分析

2024-02-197
OAAI
Optimal Time-to-Surgery Recommendations Based on Primary Tumor Volume Regression for Patients with Resectable Esophageal Cancer after Neoadjuvant Chemoradiotherapy: A Retrospective Study

新辅助放化疗后可切除食管癌患者基于原发肿瘤体积回归的最佳手术时间建议: 一项回顾性研究

2024-01-273
PRE